Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
10.57
+0.55 (5.49%)
At close: Aug 13, 2025, 4:00 PM
10.39
-0.18 (-1.70%)
Pre-market: Aug 14, 2025, 8:21 AM EDT
Nurix Therapeutics Employees
Nurix Therapeutics had 286 employees as of November 30, 2024. The number of employees increased by 2 or 0.70% compared to the previous year.
Employees
286
Change (1Y)
2
Growth (1Y)
0.70%
Revenue / Employee
$309,024
Profits / Employee
-$724,895
Market Cap
808.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NRIX News
- 4 weeks ago - Nurix Therapeutics Could Disrupt BTK Therapy And Reward Investors - Seeking Alpha
- 5 weeks ago - Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 5 weeks ago - European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia - GlobeNewsWire
- 2 months ago - Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström Macroglobulinemia (WM) - GlobeNewsWire
- 2 months ago - Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025) - GlobeNewsWire
- 2 months ago - Sanofi Exercises License Extension Option to Nurix's STAT6 Program - GlobeNewsWire
- 2 months ago - Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire